Alhabbab et al., 2015 - Google Patents
Diversity of gut microflora is required for the generation of B cell with regulatory properties in a skin graft modelAlhabbab et al., 2015
View HTML- Document ID
- 18207463858946832696
- Author
- Alhabbab R
- Blair P
- Elgueta R
- Stolarczyk E
- Marks E
- Becker P
- Ratnasothy K
- Smyth L
- Safinia N
- Sharif-Paghaleh E
- O’Connell S
- Noelle R
- Lord G
- Howard J
- Spencer J
- Lechler R
- Lombardi G
- Publication year
- Publication venue
- Scientific reports
External Links
Snippet
B cells have been reported to promote graft rejection through alloantibody production. However, there is growing evidence that B cells can contribute to the maintenance of tolerance. Here, we used a mouse model of MHC-class I mismatched skin transplantation to …
- 210000003491 Skin 0 title abstract description 65
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alhabbab et al. | Diversity of gut microflora is required for the generation of B cell with regulatory properties in a skin graft model | |
Martinez-Lopez et al. | Microbiota sensing by Mincle-Syk axis in dendritic cells regulates interleukin-17 and-22 production and promotes intestinal barrier integrity | |
Toubal et al. | Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity | |
Mao et al. | Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism | |
Calcinotto et al. | Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression | |
Diehl et al. | Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX3CR1hi cells | |
Zhuang et al. | Graft-infiltrating host dendritic cells play a key role in organ transplant rejection | |
Nova-Lamperti et al. | IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+ T-cell responses | |
Shin et al. | Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+ CD25+ Foxp3+ regulatory T cells | |
Diana et al. | Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes | |
Berer et al. | Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination | |
Karim et al. | Alloantigen-induced CD25+ CD4+ regulatory T cells can develop in vivo from CD25− CD4+ precursors in a thymus-independent process | |
Hu et al. | Maternal antibiotic treatment protects offspring from diabetes development in nonobese diabetic mice by generation of tolerogenic APCs | |
Phan et al. | Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation | |
Mosconi et al. | Intestinal bacteria induce TSLP to promote mutualistic T-cell responses | |
Bieber et al. | T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita | |
Fu et al. | Self-recognition of the endothelium enables regulatory T-cell trafficking and defines the kinetics of immune regulation | |
Nakanishi et al. | Regulatory T cells with superior immunosuppressive capacity emigrate from the inflamed colon to draining lymph nodes | |
Biswas et al. | Negative regulation of Toll‐like receptor signaling plays an essential role in homeostasis of the intestine | |
Kuo et al. | Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and-infected mice | |
Kurkó et al. | Suppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrow | |
Liu et al. | Dysfunction of CD19+ CD24hiCD27+ B regulatory cells in patients with bullous pemphigoid | |
Koyama et al. | Promoting regulation via the inhibition of DNAM-1 after transplantation | |
Mencarelli et al. | Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis | |
Alhabbab et al. | Galectin-1 is required for the regulatory function of B cells |